Meet our provider staff
Srilata Gundala, MD
Hematology & Oncology | Founder & Principal Investigator
Srilata Gundala, MD is a board-certified Hematologist and Medical Oncologist with extensive experience as a Principal Investigator on industry-sponsored and investigator-initiated oncology trials. She brings deep expertise across solid tumors and hematologic malignancies, with a strong reputation for protocol fidelity, patient safety oversight, and high-quality data execution.
As Founder of Hope & Healing, Dr. Gundala has built a high-performing research infrastructure supported by a robust oncology patient population. Leveraging her clinical leadership and business acumen, she has expanded research operations through Hope & Healing Clinical Research LLC, enabling diversified trial execution beyond oncology.
Through strategic partnerships with experienced physicians across multiple therapeutic areas, Dr. Gundala offers sponsors a scalable, enrollment-driven research model with strong feasibility capabilities, reliable execution, and access to real-world patient populations.
Ellen Gustafson, MD
Hematology & Oncology | Senior Physician & Clinical Trials Sub-Investigator
Ellen Gustafson, MD is a highly experienced Hematologist and Medical Oncologist with more than 30 years of clinical expertise and a strong track record supporting oncology clinical trials. Her deep clinical judgment across complex hematologic and solid malignancies enables high-quality protocol execution, thoughtful eligibility assessment, and strong patient safety oversight—key attributes valued by sponsors and CROs.
Dr. Gustafson is board-certified in Internal Medicine and Medical Oncology and brings extensive experience across breast cancer, rare tumors, and challenging oncology populations. As a Sub-Investigator in the Clinical Trials Program at Hope & Healing Cancer Services, she plays a critical role in study conduct, collaborating closely with multidisciplinary research teams to support enrollment, protocol adherence, and data integrity while ensuring patients have access to innovative therapies.
Her decades-long patient relationships, clinical credibility, and consistent involvement in trials make Dr. Gustafson a reliable investigator partner for oncology studies requiring experienced oversight, real-world patient populations, and high-quality site performance.
Matt Toman, MSN, FNP-C
Family Nurse Practitioner | Whole-Person Care | Oncology & Primary Care
Matt Toman, MSN, FNP-C, is a board-certified Family Nurse Practitioner with a strong clinical foundation in both oncology and primary care. He brings an integrated, whole-person approach to medicine—focusing on treating the individual as a whole rather than just managing symptoms. With over a decade of nursing experience and advanced clinical training, Matt is known for his compassionate, patient-centered care.
He currently practices at Hope and Healing Cancer Services, with hospital affiliations at Morris Hospital and Silver Cross Hospital. His work spans preventive health, chronic disease management, and oncology support, blending evidence-based medicine with a deep commitment to patient wellness and education.
Sana Meah, DO
Endocrinology | Principal / Sub-Investigator
Sana Meah, DO is a board-certified Endocrinologist and Internal Medicine physician with extensive clinical research experience, having served as a Principal Investigator and Sub-Investigator on multiple industry-sponsored trials. Her research focus includes diabetes, obesity, metabolic disorders, and hormonal conditions—areas with high sponsor demand and strong enrollment potential.
She brings deep familiarity with protocol execution, safety monitoring, and regulatory compliance, paired with access to a large, engaged endocrine patient population. Her ability to translate complex protocols into real-world care supports strong recruitment, retention, and data quality.
Dr. Meah represents a high-value investigator partner for endocrinology and cardiometabolic trials requiring experienced oversight and efficient enrollment.
Manohar Jethani, MD
Family.™.Emergency.Medicine.№.Principal.―.Sub‗Investigator
Manohar Jethani, MD is a highly experienced Family and Emergency Medicine physician with decades of clinical practice and extensive involvement in clinical research as both a Principal and Sub-Investigator. He is a board-certified lipidologist with direct experience conducting lipid clinical trials, bringing specialized expertise to cardiometabolic and cardiovascular research. His broad clinical background supports studies requiring wide inclusion criteria, acute care insight, and diverse adult populations.
He offers a large, well-established patient base, strong clinical judgment, and deep experience managing complex chronic conditions commonly targeted in primary care and population health trials. His long-standing patient relationships enable efficient patient identification, recruitment, and retention. Dr. Jethani is particularly well positioned for lipid, cardiometabolic, vaccine, and chronic disease trials requiring real-world applicability, regulatory reliability, and consistent execution.
Anuj Jain, MD
Family Medicine | Research-Ready Investigator
Anuj Jain, MD is a board-certified Family Medicine physician with a strong interest in clinical research and a robust, diverse primary care patient database. His practice includes high-volume management of chronic diseases commonly targeted in sponsor pipelines, including diabetes, hypertension, and cardiometabolic conditions.
While early in formal research experience, Dr. Jain is research-ready and supported by an established research infrastructure. His patient continuity, visit volume, and trusted relationships position him well for efficient recruitment and retention.
Dr. Jain is an attractive investigator for real-world primary care, prevention, and chronic disease studies requiring rapid feasibility and scalable enrollment.
Veena Prabhu, MD
Internal Medicine | Research-Focused Physician
Veena Prabhu, MD is a board-certified Internal Medicine physician with a strong interest in participating in clinical research and a thriving, longitudinal adult patient population. Her practice supports high feasibility for studies in preventive care, cardiometabolic disease, vaccines, and chronic condition management.
Although early in formal trial experience, Dr. Prabhu brings significant value through patient access, continuity of care, and real-world disease prevalence, all supported by a centralized research team.
She represents an excellent opportunity for sponsors seeking new investigator development with immediate enrollment capability in primary care and internal medicine trials.
Prabhu Shivalingappa, MD
Internal Medicine | Research-Ready Primary Care Investigator
Prahub Shivalingappa, MD is a board-certified Internist with more than two decades of clinical experience and a large, well-maintained patient database spanning adult and geriatric populations. His practice is ideally suited for studies targeting chronic disease, preventive medicine, and population health.
He has a strong interest in expanding into clinical research and brings key sponsor-valued assets: high patient volume, strong continuity, and deep insight into real-world disease management. Supported by experienced research operations, he is positioned for rapid onboarding and execution.
Dr. Shivalingappa is well suited for cardiometabolic, vaccines, internal medicine, and preventive care trials requiring efficient recruitment and reliable site performance.
Hong S. Lee, MD
Endocrinology, Diabetes & Metabolism | Clinical Investigator & Strategic Research Partner
Hong S. Lee, MD is a board-certified endocrinologist with more than two decades of clinical experience and a strong academic foundation that supports high-quality clinical research. He earned his MD from the University of Minnesota Medical School and completed his Internal Medicine residency followed by a fellowship in Endocrinology, Diabetes & Metabolism at Loyola University Chicago. Dr. Lee’s clinical expertise spans diabetes (Type 1 & 2), thyroid disorders and cancer, metabolic syndrome, osteoporosis, and PCOS—making him well-suited for endocrinology and metabolic clinical trials.
As a clinical investigator and research partner, Dr. Lee brings a patient-centered approach, access to diverse and well-characterized patient populations, and a strong commitment to protocol adherence and data quality. His academic involvement and participation in professional endocrine societies enhance his ability to support sponsor-driven and investigator-initiated studies, positioning him as a reliable collaborator for sponsors and CROs seeking efficient trial execution and meaningful scientific outcomes.